Rocket


News + Filings
Transactions
Holdings





NBVM GP, LLC

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
04/12/2022Lyra Therapeutics, Inc.LYRAPurchaseCommon Stock765k$4.22$3.2MSee footnote04/12/2022
04/12/2022Lyra Therapeutics, Inc.LYRAPurchaseCommon Stock527.8k$4.22$2.2MSee footnote04/12/2022
04/12/2022Lyra Therapeutics, Inc.LYRAPurchaseCommon Stock1.1M$4.22$4.5MSee footnote04/12/2022
07/26/2021Couchbase, Inc. ConversionSeries A Preferred Stock643.7k$0.00$0By: North Bridge Venture Partners VI, L.P.07/26/2021
07/26/2021Couchbase, Inc. ConversionSeries B Preferred Stock498.9k$0.00$0By: North Bridge Venture Partners 7, L.P.07/26/2021
07/26/2021Couchbase, Inc. ConversionSeries B Preferred Stock498.9k$0.00$0By: North Bridge Venture Partners VI, L.P.07/26/2021
07/26/2021Couchbase, Inc. ConversionSeries C Preferred Stock317.9k$0.00$0By: North Bridge Venture Partners 7, L.P.07/26/2021
07/26/2021Couchbase, Inc. ConversionSeries C Preferred Stock317.9k$0.00$0By: North Bridge Venture Partners VI, L.P.07/26/2021
07/26/2021Couchbase, Inc. ConversionSeries D Preferred Stock201k$0.00$0By: North Bridge Venture Partners 7, L.P.07/26/2021
07/26/2021Couchbase, Inc. ConversionSeries D Preferred Stock86.2k$0.00$0By: North Bridge Venture Partners VI, L.P.07/26/2021
07/26/2021Couchbase, Inc. ConversionCommon Stock2.4M$0.00$0By: North Bridge Venture Partners 7, L.P.07/26/2021
07/26/2021Couchbase, Inc. ConversionCommon Stock1.9M$0.00$0By: North Bridge Venture Partners VI, L.P.07/26/2021
07/26/2021Couchbase, Inc. PurchaseCommon Stock94.8k$24.00$2.3MBy: North Bridge Venture Partners 7, L.P.07/26/2021
07/26/2021Couchbase, Inc. PurchaseCommon Stock40.6k$24.00$975kBy: North Bridge Venture Partners VI, L.P.07/26/2021
07/26/2021Couchbase, Inc. ConversionSeries A Preferred Stock643.7k$0.00$0By: North Bridge Venture Partners 7, L.P.07/26/2021
07/26/2021Couchbase, Inc. ConversionSeries E Preferred Stock94k$0.00$0By: North Bridge Venture Partners 7, L.P.07/26/2021
07/26/2021Couchbase, Inc. ConversionSeries E Preferred Stock40.3k$0.00$0By: North Bridge Venture Partners VI, L.P.07/26/2021
07/26/2021Couchbase, Inc. ConversionSeries F Preferred Stock131.8k$0.00$0By: North Bridge Venture Partners 7, L.P.07/26/2021
07/26/2021Couchbase, Inc. ConversionSeries F Preferred Stock56.5k$0.00$0By: North Bridge Venture Partners VI, L.P.07/26/2021
07/26/2021Couchbase, Inc. ConversionSeries G Preferred Stock477.9k$0.00$0By: North Bridge Venture Partners 7, L.P.07/26/2021
07/26/2021Couchbase, Inc. ConversionSeries G Preferred Stock204.8k$0.00$0By: North Bridge Venture Partners VI, L.P.07/26/2021
05/05/2020Lyra Therapeutics, Inc.LYRAConversionCommon Stock651.5k$0.00$0See footnote05/05/2020
05/05/2020Lyra Therapeutics, Inc.LYRAConversionCommon Stock319.3k$0.00$0See footnote05/05/2020
05/05/2020Lyra Therapeutics, Inc.LYRAConversionCommon Stock471.9k$0.00$0See footnote05/05/2020
05/05/2020Lyra Therapeutics, Inc.LYRASaleCommon Stock11.4k$16.00$181.8kSee footnote05/05/2020
05/05/2020Lyra Therapeutics, Inc.LYRASaleCommon Stock5.6k$16.00$89.1kSee footnote05/05/2020
05/05/2020Lyra Therapeutics, Inc.LYRASaleCommon Stock7.3k$16.00$116.1kSee footnote05/05/2020
05/05/2020Lyra Therapeutics, Inc.LYRAPurchaseCommon Stock117.4k$16.00$1.9MSee Footnote05/05/2020
05/05/2020Lyra Therapeutics, Inc.LYRAPurchaseCommon Stock57.6k$16.00$921kSee Footnote05/05/2020
05/05/2020Lyra Therapeutics, Inc.LYRAPurchaseCommon Stock75k$16.00$1.2MSee Footnote05/05/2020
05/05/2020Lyra Therapeutics, Inc.LYRAConversionSeries A-1/A Convertible Preferred Stock1.2M$0.00$0See footnote05/05/2020
05/05/2020Lyra Therapeutics, Inc.LYRAConversionSeries A-1/A Convertible Preferred Stock567.4k$0.00$0See footnote05/05/2020
05/05/2020Lyra Therapeutics, Inc.LYRAConversionSeries A-1/A Convertible Preferred Stock1.7M$0.00$0See footnote05/05/2020
05/05/2020Lyra Therapeutics, Inc.LYRAConversionSeries A-1/B Convertible Preferred Stock1.1M$0.00$0See footnote05/05/2020
05/05/2020Lyra Therapeutics, Inc.LYRAConversionSeries A-1/B Convertible Preferred Stock542k$0.00$0See footnote05/05/2020
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy